Mazindol combination in the treatment of attention...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4188 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2648943

The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms.

La présente invention concerne le domaine de la santé humaine et plus particulièrement le traitement du trouble déficit de l'attention/hyper-activité (TDAH) par le mazindol. Ce dernier peut être administré monothérapie ou en association avec un ou plusieurs composés, y compris des psychostimulants, pour l'indication de TDAH et des symptômes associés ou comorbides.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mazindol combination in the treatment of attention... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mazindol combination in the treatment of attention..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mazindol combination in the treatment of attention... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1902630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.